Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
International Immunopharmacology|January 4, 2026
Leveraging SARS-CoV-2-induced pre-existing humoral and cellular immunity for tumor eliminationLingxiao Chen, Qiumin Yu, Shukang Duan, et al.The Journal of Pharmacology and Experimental Therapeutics|April 23, 2025
Enhanced efficiency of MHC class II tumor neoantigen vaccines with a novel CD4+ T-cell helper epitopeQiuli Mao, Yahong Tian, Qiumin Yu, et al.Cancer Immunology, Immunotherapy : CII|April 29, 2023
Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccinesYanliang Kang, Wanli Zhang, Qiumin Yu, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2024
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapyWanli Zhang, Xupeiyao Shi, Shitong Huang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2025
Restoring tumor antigenicity activates the "bystander" T cell immune cycleYifan Yang, Qiumin Yu, Haoyu Zhang, et al.Immunology|August 22, 2024
Altered epitopes enhance macrophage-mediated anti-tumour immunity to low-immunogenic tumour mutationsQiumin Yu, Tingran Zhang, Tiandi He, et al.Pageof 1